Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF

Por Jhund, Pardeep S., Fu, Michael, Bayram, Edmundo, Chen, Chen-Huan, Negrusz-Kawecka, Marta, Rosenthal, Arvo, Desai, Akshay S., Lefkowitz, Martin P., Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Solomon, Scott D., Swedberg, Karl, Zile, Michael R., McMurray, John J.V., Packer, Milton
Publicado no Eur Heart J (2015)

A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure

Por McMurray, John, Packer, Milton, Desai, Akshay, Gong, Jianjian, Greenlaw, Nicola, Lefkowitz, Martin, Rizkala, Adel, Shi, Victor, Rouleau, Jean, Solomon, Scott, Swedberg, Karl, Zile, Michael R., Andersen, Karl, Arango, Juan Luis, Arnold, Malcolm, Be˘lohlávek, Jan, Böhm, Michael, Boytsov, Sergey, Burgess, Lesley, Cabrera, Walter, Chen, Chen-Huan, Erglis, Andrejs, Fu, Michael, Gomez, Efrain, Gonzalez, Angel, Hagege, Albert-Alain, Katova, Tzvetana, Kiatchoosakun, Songsak, Kim, Kee-Sik, Bayram, Edmundo, Martinez, Felipe, Merkely, Bela, Mendoza, Iván, Mosterd, Arend, Negrusz-Kawecka, Marta, Peuhkurinen, Keijo, Ramires, Felix, Refsgaard, Jens, Senni, Michele, Sibulo, Antonio S., Silva-Cardoso, José, Squire, Iain, Starling, Randall C., Vinereanu, Dragos, Teerlink, John R., Wong, Raymond
Publicado no Eur Heart J (2015)